Financials

  • Market Capitalization 521.45 M
  • Employee 23
  • Founded 2014
  • CEO N/A
  • Website www.ovidrx.com
  • Headquarter Delaware, United States
  • FIGI BBG009F0TD76
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-12.81
Fiyat/satışlar oranı
168.21

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
2887
CABA
Cabaletta Bio, Inc. - Common Stock
3.11 USD-0.32%-1.58%+16.48%+111.56%527.29 M USD
2888
KYTX
Kyverna Therapeutics, Inc. - Common Stock
8.48 USD+1.31%+1.44%+16.97%+136.21%524.43 M USD
2906
ENTX
Entera Bio Ltd. - Ordinary Shares
2.95 USD-2.64%-13.74%+1.37%+52.06%510.77 M USD
2940
PRTA
Prothena Corporation plc - Ordinary Shares
9.35 USD+0.21%-1.68%+14.44%+14.44%480.00 M USD

Haberler